Jackson Square Capital, LLC Merck & Co., Inc. Transaction History

Jackson Square Capital, LLC

$383 Million
Q4 2024

A detailed history of Jackson Square Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jackson Square Capital, LLC holds 6,164 shares of MRK stock, worth $553,280. This represents 0.16% of its overall portfolio holdings.

Number of Shares

6,164

Previous 21,848 71.79%

Holding current value

$553,280

Previous $2.48 Million 75.29%

% of portfolio

0.16%

Previous 0.65%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$96.31 - $114.76 $1.51 Million - $1.8 Million	-15,684 Reduced 71.79%	6,164 $613,000
Q3 2024 Oct 31, 2024	SELL	$111.15 - $128.97 $3.46 Million - $4.02 Million	-31,156 Reduced 58.78%	21,848 $2.48 Million
Q2 2024 Aug 05, 2024	BUY	$123.8 - $132.96 $94,088 - $101,049	760 Added 1.45%	53,004 $6.56 Million
Q1 2024 Apr 16, 2024	BUY	$113.24 - $131.95 $1.77 Million - $2.06 Million	15,615 Added 42.63%	52,244 $6.89 Million
Q4 2023 Jan 09, 2024	BUY	$100.18 - $109.02 $7,914 - $8,612	79 Added 0.22%	36,629 $3.99 Million
Q3 2023 Oct 25, 2023	SELL	$102.95 - $114.33 $924,079 - $1.03 Million	-8,976 Reduced 19.72%	36,550 $3.76 Million
Q2 2023 Jul 28, 2023	SELL	$108.61 - $118.38 $48,874 - $53,271	-450 Reduced 0.98%	45,526 $5.25 Million
Q1 2023 Apr 21, 2023	BUY	$102.94 - $114.86 $4.03 Million - $4.49 Million	39,119 Added 570.5%	45,976 $4.89 Million
Q4 2022 Jan 23, 2023	SELL	$87.44 - $112.11 $1,136 - $1,457	-13 Reduced 0.19%	6,857 $0
Q3 2022 Oct 13, 2022	BUY	$84.53 - $94.96 $6,424 - $7,216	76 Added 1.12%	6,870 $592,000
Q2 2022 Jul 25, 2022	SELL	$83.49 - $94.64 $2,588 - $2,933	-31 Reduced 0.45%	6,794 $619,000
Q1 2022 Apr 20, 2022	SELL	$73.51 - $82.4 $63,218 - $70,864	-860 Reduced 11.19%	6,825 $560,000
Q4 2021 Jan 19, 2022	BUY	$72.28 - $90.54 $280,085 - $350,842	3,875 Added 101.71%	7,685 $589,000
Q3 2021 Oct 21, 2021	BUY	$71.68 - $78.83 $67,809 - $74,573	946 Added 33.03%	3,810 $286,000
Q2 2021 Jul 20, 2021	SELL	$70.31 - $77.77 $355,135 - $392,816	-5,051 Reduced 63.82%	2,864 $223,000
Q1 2021 May 18, 2021	SELL	$68.86 - $81.11 $1.5 Million - $1.77 Million	-21,835 Reduced 73.39%	7,915 $610,000
Q4 2020 Mar 05, 2021	SELL	$71.77 - $79.65 $254,352 - $282,279	-3,544 Reduced 10.64%	29,750 $2.43 Million
Q3 2020 Nov 17, 2020	SELL	$73.18 - $82.95 $213,466 - $241,965	-2,917 Reduced 8.06%	33,294 $2.76 Million
Q2 2020 Aug 18, 2020	BUY	$70.42 - $80.13 $1.69 Million - $1.92 Million	23,964 Added 195.67%	36,211 $2.8 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $115,948 - $160,710	1,830 Added 17.57%	12,247 $942,000
Q4 2019 May 15, 2020	BUY	$77.58 - $87.54 $808,150 - $911,904	10,417 New	10,417 $947,000

Others Institutions Holding MRK

# of Institutions

3,974

Shares Held

1.86B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Capital, LLC with notifications on news.

Account

Jackson Square Capital, LLC Merck & Co., Inc. Transaction History